• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

橄榄营养保健品对蛋白酪氨酸激酶的靶向特异性抑制及其与癌症和SARS-CoV-2的关联

Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals.

作者信息

Ghosh Arabinda, Mukerjee Nobendu, Sharma Bhavdeep, Pant Anushree, Kishore Mohanta Yugal, Jawarkar Rahul D, Bakal Ravindrakumar L, Terefe Ermias Mergia, Batiha Gaber El-Saber, Mostafa-Hedeab Gomaa, Aref Albezrah Nisreen Khalid, Dey Abhijit, Baishya Debabrat

机构信息

Microbiology Division, Department of Botany, Gauhati University, Guwahati, India.

Department of Microbiology, Ramakrishna Mission Vivekananda Centenary College, Kolkata, India.

出版信息

Front Pharmacol. 2022 Mar 8;12:812565. doi: 10.3389/fphar.2021.812565. eCollection 2021.

DOI:10.3389/fphar.2021.812565
PMID:35356629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8959131/
Abstract

The fact that viruses cause human cancer dates back to the early 1980s. By reprogramming cellular signaling pathways, viruses encoded protein that can regulate altered control of cell cycle events. Viruses can interact with a superfamily of membrane bound protein, receptor tyrosine kinase to modulate their activity in order to increase virus entrance into cells and promotion of viral replication within the host. Therefore, our study aimed at screening of inhibitors of tyrosine kinase using natural compounds from olive. Protein tyrosine kinase (PTK) is an important factor for cancer progression and can be linked to coronavirus. It is evident that over expression of Protein tyrosine kinase (PTK) enhance viral endocytosis and proliferation and the use of tyrosine kinase inhibitors reduced the period of infection period. Functional network studies were carried out using two major PTKs viz. Anaplastic lymphoma kinase (ALK) and B-lymphocytic kinase (BTK). They are associated with coronavirus in regulation of cell signaling proteins for cellular processes. We virtually screened for 161 library of natural compounds from olive found overexpressed in ALK and BTK in metastatic as well as virus host cells. We have employed both ligand and target-based approach for drug designing by high throughput screening using Multilinear regression model based QSAR and docking. The QSAR based virtual screening of 161 olive nutraceutical compounds has successfully identified certain new hit; Wedelosin, in which, the descriptor rsa (ratio of molecular surface area to the solvent accessible surface area) plays crucial role in deciding Wedelosin's inhibitory potency. The best-docked olive nutraceuticals further investigated for the stability and effectivity of the BTK and ALK during in 150 ns molecular dynamics and simulation. Post simulation analysis and binding energy estimation in MMGBSA further revealed the intensive potential of the olive nutraceuticals in PTK inhibition. This study is therefore expected to widen the use of nutraceuticals from olive in cancer as well as SARS-CoV2 alternative therapy.

摘要

病毒导致人类癌症这一事实可追溯到20世纪80年代初。通过重新编程细胞信号通路,病毒编码的蛋白质可以调节细胞周期事件的改变控制。病毒可以与膜结合蛋白的一个超家族——受体酪氨酸激酶相互作用,以调节其活性,从而增加病毒进入细胞的机会并促进病毒在宿主体内的复制。因此,我们的研究旨在使用来自橄榄的天然化合物筛选酪氨酸激酶抑制剂。蛋白酪氨酸激酶(PTK)是癌症进展的一个重要因素,并且可能与冠状病毒有关。很明显,蛋白酪氨酸激酶(PTK)的过度表达会增强病毒的内吞作用和增殖,而使用酪氨酸激酶抑制剂可以缩短感染期。使用两种主要的PTK,即间变性淋巴瘤激酶(ALK)和B淋巴细胞激酶(BTK)进行了功能网络研究。它们在调节细胞信号蛋白以参与细胞过程中与冠状病毒有关。我们对在转移性以及病毒宿主细胞中ALK和BTK中过表达的161种橄榄天然化合物文库进行了虚拟筛选。我们采用了基于配体和基于靶点的方法,通过使用基于多线性回归模型的QSAR和对接进行高通量筛选来进行药物设计。对161种橄榄营养化合物进行的基于QSAR的虚拟筛选成功鉴定出了某些新的命中物;wedelosin,其中,描述符rsa(分子表面积与溶剂可及表面积之比)在决定wedelosin的抑制效力中起关键作用。对对接效果最佳的橄榄营养化合物进一步研究了其在150纳秒分子动力学和模拟过程中对BTK和ALK的稳定性和有效性。MMGBSA中的模拟后分析和结合能估计进一步揭示了橄榄营养化合物在抑制PTK方面的巨大潜力。因此,预计这项研究将扩大橄榄营养化合物在癌症以及SARS-CoV2替代疗法中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/87721d3cf4a3/fphar-12-812565-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/121b930341e6/fphar-12-812565-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/1b2383306a57/fphar-12-812565-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/9bd2c55aadf5/fphar-12-812565-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/f6dd1c679319/fphar-12-812565-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/64256103849c/fphar-12-812565-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/1acfc4783191/fphar-12-812565-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/c777152c7518/fphar-12-812565-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/eb3cd0a2d894/fphar-12-812565-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/8d737496dfee/fphar-12-812565-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/169ffa6febc2/fphar-12-812565-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/f925e4814018/fphar-12-812565-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/87721d3cf4a3/fphar-12-812565-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/121b930341e6/fphar-12-812565-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/1b2383306a57/fphar-12-812565-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/9bd2c55aadf5/fphar-12-812565-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/f6dd1c679319/fphar-12-812565-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/64256103849c/fphar-12-812565-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/1acfc4783191/fphar-12-812565-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/c777152c7518/fphar-12-812565-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/eb3cd0a2d894/fphar-12-812565-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/8d737496dfee/fphar-12-812565-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/169ffa6febc2/fphar-12-812565-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/f925e4814018/fphar-12-812565-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f73/8959131/87721d3cf4a3/fphar-12-812565-g012.jpg

相似文献

1
Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals.橄榄营养保健品对蛋白酪氨酸激酶的靶向特异性抑制及其与癌症和SARS-CoV-2的关联
Front Pharmacol. 2022 Mar 8;12:812565. doi: 10.3389/fphar.2021.812565. eCollection 2021.
2
QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophoric Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads.QSAR、分子对接、MD 模拟和 MMGBSA 计算方法识别优化 ALK 酪氨酸激酶抑制剂为抗癌先导所需的隐藏药效团特征。
Molecules. 2022 Aug 3;27(15):4951. doi: 10.3390/molecules27154951.
3
Molecular modeling studies on series of Btk inhibitors using docking, structure-based 3D-QSAR and molecular dynamics simulation: a combined approach.使用对接、基于结构的3D-QSAR和分子动力学模拟对一系列布鲁顿酪氨酸激酶(Btk)抑制剂进行分子建模研究:一种联合方法。
Arch Pharm Res. 2016 Mar;39(3):328-39. doi: 10.1007/s12272-015-0698-0. Epub 2015 Dec 23.
4
Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation.通过三维定量构效关系建模和分子动力学模拟探索布鲁顿酪氨酸激酶的新型抑制剂
PLoS One. 2016 Jan 19;11(1):e0147190. doi: 10.1371/journal.pone.0147190. eCollection 2016.
5
Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.基于药效团模型的虚拟筛选寻找新型布鲁顿酪氨酸激酶抑制剂
J Mol Model. 2019 Jun 6;25(7):179. doi: 10.1007/s00894-019-4047-y.
6
Combined pharmacophore, virtual screening and molecular dynamics studies to identify Bruton's tyrosine kinase inhibitors.基于药效基团、虚拟筛选和分子动力学研究鉴定布鲁顿酪氨酸激酶抑制剂。
J Biomol Struct Dyn. 2018 Dec;36(16):4320-4337. doi: 10.1080/07391102.2017.1415821. Epub 2018 Jan 3.
7
QSAR analysis of nicotinamidic compounds and design of potential Bruton's tyrosine kinase (Btk) inhibitors.烟酰胺类化合物的定量构效关系分析及潜在布鲁顿酪氨酸激酶(Btk)抑制剂的设计。
J Biomol Struct Dyn. 2016 Jul;34(7):1421-40. doi: 10.1080/07391102.2015.1070750. Epub 2016 May 11.
8
Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation.使用电子药效团建模、定量构效关系和分子动力学模拟从针对严重急性呼吸综合征冠状病毒2的3C样蛋白酶的大型天然产物库中鉴定先导化合物。
In Silico Pharmacol. 2021 Aug 7;9(1):49. doi: 10.1007/s40203-021-00109-7. eCollection 2021.
9
Role of the subcellular localization of ALK tyrosine kinase domain in neuronal differentiation of PC12 cells.间变性淋巴瘤激酶(ALK)酪氨酸激酶结构域的亚细胞定位在PC12细胞神经元分化中的作用。
J Cell Sci. 2005 Dec 15;118(Pt 24):5811-23. doi: 10.1242/jcs.02695. Epub 2005 Nov 29.
10
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.

引用本文的文献

1
Rational design of allosteric inhibitors targeting C797S mutant EGFR in NSCLC: an integrative in silico and study.非小细胞肺癌中靶向C797S突变型表皮生长因子受体的变构抑制剂的合理设计:一项计算机模拟与实验相结合的研究
Front Oncol. 2025 Apr 28;15:1590779. doi: 10.3389/fonc.2025.1590779. eCollection 2025.
2
Estrogen Receptor Alpha Binders for Hormone-Dependent Forms of Breast Cancer: e-QSAR and Molecular Docking Supported by X-ray Resolved Structures.用于激素依赖性乳腺癌的雌激素受体α结合剂:基于X射线解析结构支持的电子定量构效关系和分子对接
ACS Omega. 2024 Mar 29;9(14):16759-16774. doi: 10.1021/acsomega.4c00906. eCollection 2024 Apr 9.
3

本文引用的文献

1
Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review.布鲁顿酪氨酸激酶抑制剂作为COVID-19的潜在治疗药物:综述
Metabol Open. 2021 Sep;11:100116. doi: 10.1016/j.metop.2021.100116. Epub 2021 Jul 29.
2
Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M: Bioinformatics Approach.大环内酯素 A 作为新型 SARS-CoV-2 M 抑制剂:生物信息学方法。
Appl Biochem Biotechnol. 2021 Oct;193(10):3371-3394. doi: 10.1007/s12010-021-03608-7. Epub 2021 Jul 1.
3
A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2.
Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro's revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder.
基于计算机的药物发现技术在发现针对 SARS-CoV-2 Mpro 的新型靶标特异性抑制剂方面的应用:与 MAO-B 受体的变构结合揭示:针对新冠后神经紊乱的治疗方法的理论研究。
PLoS One. 2024 Jan 16;19(1):e0286848. doi: 10.1371/journal.pone.0286848. eCollection 2024.
4
Pentafuhalol-B, a Phlorotannin from Brown Algae, Strongly Inhibits the PLK-1 Overexpression in Cancer Cells as Revealed by Computational Analysis.五氟卤-B,一种来自褐藻的岩藻黄质,通过计算分析显示,其强烈抑制癌细胞中 PLK-1 的过表达。
Molecules. 2023 Aug 3;28(15):5853. doi: 10.3390/molecules28155853.
5
Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategies.了解新型冠状病毒肺炎相关心肌炎:病理生理学、诊断及治疗策略
Cardiol Plus. 2023 Apr-Jun;8(2):72-81. doi: 10.1097/CP9.0000000000000046. Epub 2023 Apr 14.
6
In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators.通过计算机模拟研究来识别将精氨酸酶-I抑制剂重新用作潜在肿瘤免疫调节剂的疗法。
Front Pharmacol. 2023 Apr 18;14:1129997. doi: 10.3389/fphar.2023.1129997. eCollection 2023.
7
Combination of , and Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology?在短期阿霉素介导的心脏毒性临床前模型中,[具体物质1]、[具体物质2]和[具体物质3]的联合使用改善心脏功能并降低促炎生物标志物:心脏肿瘤学的新前沿? (注:原文中部分内容缺失,用[具体物质1]等表示)
J Cardiovasc Dev Dis. 2022 Nov 28;9(12):423. doi: 10.3390/jcdd9120423.
8
The role of berberine in Covid-19: potential adjunct therapy.小檗碱在新冠病毒肺炎中的作用:一种潜在的辅助治疗方法。
Inflammopharmacology. 2022 Dec;30(6):2003-2016. doi: 10.1007/s10787-022-01080-1. Epub 2022 Oct 2.
9
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors.靶向细胞周期蛋白依赖性激酶 1(CDK1)治疗癌症:潜在 CDK1 抑制剂的分子对接和动态模拟。
Med Oncol. 2022 Jun 20;39(9):133. doi: 10.1007/s12032-022-01748-2.
一种用于理性发现 SARS-CoV-2 的非结构蛋白 1 抑制剂的计算方法。
Comput Biol Med. 2021 Aug;135:104555. doi: 10.1016/j.compbiomed.2021.104555. Epub 2021 Jun 8.
4
The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer.SARS-CoV-2 与癌症中酪氨酸激酶受体信号的相互干扰。
Int J Mol Sci. 2021 May 2;22(9):4830. doi: 10.3390/ijms22094830.
5
QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human -Myristoyltransferase (Hs-NMT) Inhibitors.氮杂环作为有效的人酰基转移酶(Hs-NMT)抑制剂的定量构效关系和药效团建模。
Molecules. 2021 Mar 24;26(7):1834. doi: 10.3390/molecules26071834.
6
Epoxyquinophomopsins A and B from endophytic fungus Phomopsis sp. and their activity against tyrosine kinase.环氧醌霉素 A 和 B 来自内生真菌拟茎点霉属和它们对酪氨酸激酶的活性。
J Nat Med. 2021 Jan;75(1):217-222. doi: 10.1007/s11418-020-01454-1. Epub 2020 Oct 8.
7
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.酪氨酸激酶抑制剂对慢性髓性白血病患者具有抗病毒作用:一种支持其用于抗击SARS-CoV-2的可能模型。
Front Oncol. 2020 Sep 2;10:1428. doi: 10.3389/fonc.2020.01428. eCollection 2020.
8
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.欧洲癌症患者中新型冠状病毒肺炎疫情的临床概况。
Cancer Discov. 2020 Jul 31;10(10):1465-74. doi: 10.1158/2159-8290.CD-20-0773.
9
Geo-Measures: A PyMOL plugin for protein structure ensembles analysis.地理测量:一款用于蛋白质结构集合分析的PyMOL插件。
Comput Biol Chem. 2020 Jun 24;87:107322. doi: 10.1016/j.compbiolchem.2020.107322.
10
COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors.接受ALK/ROS1抑制剂治疗的肺癌患者中的COVID-19
Eur J Cancer. 2020 Jun;132:122-124. doi: 10.1016/j.ejca.2020.04.004. Epub 2020 Apr 23.